The demand for healthcare services in the U.S. is going up because the population is getting older and more people have long-lasting diseases. But there are not enough skilled doctors, especially in areas like radiology and pathology. For example, there are only 11 radiologists for every 100,000 people. This causes delays in reading medical images and giving diagnoses. Pathology faces a similar problem because most pathologists work in a few countries, leaving many patients without enough care.
In this situation, artificial intelligence (AI) can help doctors by improving how accurate diagnoses are and making results faster. AI tools use special programs to help doctors work more efficiently. This lets them focus on harder tasks while caring for more patients.
Series C funding is an important step where companies get a large amount of money to grow their business, reach more customers, and speed up product development. In healthcare AI, this money helps companies put new tools into practice that have shown they work well and follow rules.
Two companies, Harrison.ai and Deciphex, got big Series C investments to help them grow in the U.S.
Harrison.ai is a health technology company that raised $112 million in Series C funding. This shows that investors believe AI can improve medical diagnostics in the U.S. The company works mainly in radiology and pathology, using AI to help find diseases and support doctors’ decisions.
Their technology has made diagnoses over 45% more accurate, especially for lung cancer. Their AI looks at CT scans and X-rays to find cancer earlier. Studies say that 32% of lung cancer cases could be found as much as 16 months sooner using Harrison.ai’s tools. Finding cancer early helps patients get treatment on time.
Harrison.ai’s tools are used in more than 1,000 healthcare places worldwide, including care for over six million patients each year. They work not only in Australia and the UK but are also growing in Boston, Massachusetts, to meet U.S. needs. The company has 12 cleareances from the FDA, meaning the government trusts their tools for safety and effectiveness. One of their brain scan tools even got a special FDA Breakthrough Device status and Medicare payment.
Dr. Aengus Tran, co-founder and CEO of Harrison.ai, said AI helps fill gaps caused by fewer skilled doctors and makes healthcare fairer. This supports U.S. efforts to reduce differences in care and make workflows better.
Deciphex is another example of a company using AI to help in pathology, an area with many diagnostic delays. Recently, they raised about $32.3 million in Series C funding led by Molten Ventures. This money will help them grow worldwide, especially in the U.S., U.K., European Union, Canada, and Japan.
Pathology is important because it affects more than 70% of medical results and treatment plans. But there are not enough pathologists to keep up with demand, causing delays and problems in the workflow. Deciphex created AI platforms called Diagnexia and Patholytix to make pathology faster and more accurate.
Using AI image analysis and digital pathology, Deciphex helps pathologists work on more cases without losing accuracy. This cuts down the time needed for diagnosis and helps patients get treatment sooner. With their Series C funding, Deciphex plans to improve its AI tools, make the platform bigger, and connect with healthcare and drug companies.
The company’s CEO, Donal O’Shea, said the investment speeds up their goal to make healthcare better for patients and pathologists. Jennifer McMahon, a board member at Seroba Life Sciences, mentioned Deciphex is leading the way in digital pathology and will bring clear improvements to patient care around the world.
For healthcare managers and IT staff, AI is not just about better medical results. It also helps automate many everyday tasks. Adding AI to workflows reduces paperwork, uses resources better, and improves how patients communicate and schedule appointments.
Growing access to AI diagnostic tools backed by large Series C funding has many effects for clinic managers and owners in the U.S.:
From an IT view, bringing AI and automation into healthcare has good chances but also some difficulties that need planning:
Series C funding for AI diagnostic companies like Harrison.ai and Deciphex shows growing trust that AI can change healthcare in the U.S. This money helps companies turn their products into real tools that deal with fewer doctors and make diagnoses better in radiology and pathology.
At the same time, AI also helps reduce paperwork, speeds up clinical work, and improves how patients experience care. For healthcare managers, owners, and IT staff, knowing these changes is important for choosing the right technology, growing clinical work, and meeting rules.
As the U.S. faces staff shortages and more patients, AI tools backed by big investments like Series C can play an important role in the future of diagnostics and health management.
Harrison.ai aims to scale healthcare capacity through AI-powered medical imaging diagnostic support and workflow solutions, improving early disease diagnosis and treatment decisions.
Harrison.ai secured US$112 million in its Series C funding round to support its expansion into the United States and other regions.
Harrison.ai specializes in radiology and pathology solutions that help clinicians identify signs of cancer and other critical illnesses more accurately and faster.
Harrison.ai’s technology analyzes medical images such as CT scans and X-rays, leading to increases in diagnostic accuracy—for instance, over 45% in lung cancer detection.
Harrison.ai addresses the global shortage of skilled clinicians and the rising demand for timely diagnostics across healthcare systems.
Harrison.ai is establishing a presence in Boston to focus on building its U.S. operations and expanding its customer base.
Harrison.ai has received 12 FDA clearances and has one CT brain algorithm designated as a Breakthrough Device, alongside Medicare reimbursement.
Studies indicate Harrison.ai’s AI can speed up the diagnosis of lung cancer by an average of 16 months, enabling earlier treatment and improving patient outcomes.
Harrison.ai was invited to participate in the Healthcare AI Challenge hosted by Mass General Brigham, joining other tech leaders to assess and improve AI’s application in healthcare.
Harrison.ai’s solutions are utilized in over 1,000 healthcare facilities, supporting the care of more than six million patients annually.